Enhanced Leptin Sensitivity, Reduced Adiposity, and Improved Glucose Homeostasis in Mice Lacking Exchange Protein Directly Activated by Cyclic AMP Isoform 1

REFERENCES

• Dixon JB. 2010. The effect of obesity on health outcomes. Mol. Cell. Endocrinol. 316:104–108.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Kit BK, Ogden CL. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491–497. doi:10.1001/jama.2012.39.
   PubMed Web of Science ®Google Scholar
• Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M. 2011. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377:557–567. doi:10.1016/S0140-6736(10)62037-5.
   PubMed Web of Science ®Google Scholar
• Bray GA, Ryan DH. 2012. Medical therapy for the patient with obesity. Circulation 125:1695–1703. doi:10.1161/CIRCULATIONAHA.111.026567.
   PubMed Web of Science ®Google Scholar
• Fried SK, Ricci MR, Russell CD, Laferrere B. 2000. Regulation of leptin production in humans. J. Nutr. 130:3127S–3131S.
   PubMed Web of Science ®Google Scholar
• Li H, Matheny M, Scarpace PJ. 1997. β3-Adrenergic-mediated suppression of leptin gene expression in rats. Am. J. Physiol. 272:E1031–E1036.
   PubMedGoogle Scholar
• Ricci MR, Fried SK. 1999. Isoproterenol decreases leptin expression in adipose tissue of obese humans. Obes. Res. 7:233–240.
   PubMedGoogle Scholar
• Cheng X, Ji Z, Tsalkova T, Mei F. 2008. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim. Biophys. Sin. (Shanghai) 40:651–662.
   PubMedGoogle Scholar
• de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. 1998. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477.
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM. 1998. A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275–2279.
   PubMed Web of Science ®Google Scholar
• Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL. 2002. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4:901–906.
   PubMedGoogle Scholar
• Fukuda M, Williams KW, Gautron L, Elmquist JK. 2011. Induction of leptin resistance by activation of cAMP-Epac signaling. Cell Metab. 13:331–339. doi:10.1016/j.cmet.2011.01.016.
   PubMed Web of Science ®Google Scholar
• O'Gorman S, Dagenais NA, Qian M, Marchuk Y. 1997. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 94:14602–14607.
   PubMedGoogle Scholar
• El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS. 2000. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105:1827–1832. doi:10.1172/JCI9842.
   PubMed Web of Science ®Google Scholar
• Munzberg H, Huo L, Nillni EA, Hollenberg AN, Bjorbaek C. 2003. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 144:2121–2131.
   PubMed Web of Science ®Google Scholar
• Ruiter M, Duffy P, Simasko S, Ritter RC. 2010. Increased hypothalamic signal transducer and activator of transcription 3 phosphorylation after hindbrain leptin injection. Endocrinology 151:1509–1519. doi:10.1210/en.2009-0854.
   PubMedGoogle Scholar
• Conner DA. 2001.Mouse embryonic stem (ES) cell culture. Curr. Protoc. Mol. Biol. Chapter 23:Unit 23.3. doi:10.1002/0471142727.mb2303s51.
   Google Scholar
• Rasouli N, Raue U, Miles LM, Lu T, Di Gregorio GB, Elbein SC, Kern PA. 2005. Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue. Am. J. Physiol. Endocrinol. Metab. 288:E930–E934. doi:10.1152/ajpendo.00522.2004.
   PubMed Web of Science ®Google Scholar
• Hillebrand JJ, Langhans W, Geary N. 2010. Validation of computed tomographic estimates of intra-abdominal and subcutaneous adipose tissue in rats and mice. Obesity (Silver Spring) 18:848–853. doi:10.1038/oby.2009.341.
   PubMedGoogle Scholar
• Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292–295. doi:10.1056/NEJM199602013340503.
   PubMed Web of Science ®Google Scholar
• Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395:763–770. doi:10.1038/27376.
   PubMed Web of Science ®Google Scholar
• Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1155–1161.
   PubMed Web of Science ®Google Scholar
• Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers MGJr. 2003. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421:856–859. doi:10.1038/nature01388.
   PubMed Web of Science ®Google Scholar
• Kievit P, Howard JK, Badman MK, Balthasar N, Coppari R, Mori H, Lee CE, Elmquist JK, Yoshimura A, Flier JS. 2006. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab. 4:123–132. doi:10.1016/j.cmet.2006.06.010.
   PubMed Web of Science ®Google Scholar
• Cheung CC, Clifton DK, Steiner RA. 1997. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489–4492.
   PubMed Web of Science ®Google Scholar
• Hubschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W. 2001. Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J. Neurosci. 21:2413–2424.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. 1996. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98:1101–1106. doi:10.1172/JCI118891.
   PubMed Web of Science ®Google Scholar
• Sands WA, Woolson HD, Milne GR, Rutherford C, Palmer TM. 2006. Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol. Cell. Biol. 26:6333–6346.
   PubMed Web of Science ®Google Scholar
• Carpenter LR, Farruggella TJ, Symes A, Karow ML, Yancopoulos GD, Stahl N. 1998. Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor. Proc. Natl. Acad. Sci. U. S. A. 95:6061–6066.
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M. 1999. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568–1575.
   PubMed Web of Science ®Google Scholar
• Ahren B, Baldwin RM, Havel PJ. 2000. Pharmacokinetics of human leptin in mice and rhesus monkeys. Int. J. Obes. Relat. Metab. Disord. 24:1579–1585.
   PubMed Web of Science ®Google Scholar
• Hill RA, Margetic S, Pegg GG, Gazzola C. 1998. Leptin: its pharmacokinetics and tissue distribution. Int. J. Obes. Relat. Metab. Disord. 22:765–770.
   PubMed Web of Science ®Google Scholar
• Almahariq M, Tsalkova T, Fang MC, Chen H, Zhou J, Sastry S, Schwede F, Cheng X. 2013. A novel EPAC specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol. Pharmacol. 83:122–128. doi:10.1124/mol.112.080689.
   PubMed Web of Science ®Google Scholar
• Tsalkova T, Mei FC, Li S, Chepurny OG, Leech CA, Liu T, Holz GG, Woods VLJr, Cheng X. 2012. Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc. Natl. Acad. Sci. U. S. A. 109:18613–18618. doi:10.1073/pnas.1210209109.
   PubMed Web of Science ®Google Scholar
• Berglund ED, Vianna CR, Donato JJr, Kim MH, Chuang JC, Lee CE, Lauzon DA, Lin P, Brule LJ, Scott MM, Coppari R, Elmquist JK. 2012. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J. Clin. Invest. 122:1000–1009. doi:10.1172/JCI59816.
   PubMedGoogle Scholar
• Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS. 2004. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10:734–738. doi:10.1038/nm1072.
   PubMed Web of Science ®Google Scholar
• Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A. 2004. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat. Med. 10:739–743. doi:10.1038/nm1071.
   PubMed Web of Science ®Google Scholar
• Poppe H, Rybalkin SD, Rehmann H, Hinds TR, Tang XB, Christensen AE, Schwede F, Genieser HG, Bos JL, Doskeland SO, Beavo JA, Butt E. 2008. Cyclic nucleotide analogs as probes of signaling pathways. Nat. Methods 5:277–278.
   PubMedGoogle Scholar
• Enyeart JA, Enyeart JJ. 2009. Metabolites of an Epac-selective cAMP analog induce cortisol synthesis by adrenocortical cells through a cAMP-independent pathway. PLoS One 4:e6088. doi:10.1371/journal.pone.0006088.
   PubMedGoogle Scholar
• Enyeart JA, Liu H, Enyeart JJ. 2010. cAMP analogs and their metabolites enhance TREK-1 mRNA and K+ current expression in adrenocortical cells. Mol. Pharmacol. 77:469–482. doi:10.1124/mol.109.061861.
   PubMedGoogle Scholar
• Enyeart JA, Liu H, Enyeart JJ. 2011. 8-Phenylthio-adenines stimulate the expression of steroid hydroxylases, Cav3.2 Ca(2) channels, and cortisol synthesis by a cAMP-independent mechanism. Am. J. Physiol. Endocrinol. Metab. 301:E941–E954. doi:10.1152/ajpendo.00282.2011.
   PubMedGoogle Scholar
• Sand C, Grandoch M, Borgermann C, Oude Weernink PA, Mahlke Y, Schwindenhammer B, Weber AA, Fischer JW, Jakobs KH, Schmidt M. 2010. 8-pCPT-conjugated cyclic AMP analogs exert thromboxane receptor antagonistic properties. Thromb. Haemost. 103:662–678. doi:10.1160/TH09-06-0341.
   PubMedGoogle Scholar
• Shibasaki T, Takahashi H, Miki T, Sunaga Y, Matsumura K, Yamanaka M, Zhang C, Tamamoto A, Satoh T, Miyazaki J, Seino S. 2007. Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc. Natl. Acad. Sci. U. S. A. 104:19333–19338.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shu X, Liu D, Shang Y, Wu Y, Pei L, Xu X, Tian Q, Zhang J, Qian K, Wang YX, Petralia RS, Tu W, Zhu LQ, Wang JZ, Lu Y. 2012. EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron 73:774–788. doi:10.1016/j.neuron.2012.02.003.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, Yokoi N, Iwasaki M, Miki T, Seino S. 2009. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325:607–610.
   PubMed Web of Science ®Google Scholar
• Ji Z, Mei FC, Cheng X. 2010. Epac, not PKA catalytic subunit, is required for 3T3-L1 preadipocyte differentiation. Front. Biosci. 2:392–398.
   Google Scholar
• Martini CN, Plaza MV, Vila MC. 2009. PKA-dependent and independent cAMP signaling in 3T3-L1 fibroblasts differentiation. Mol. Cell. Endocrinol. 298:42–47. doi:10.1016/j.mce.2008.10.023.
   PubMed Web of Science ®Google Scholar
• Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, Doskeland SO, Kristiansen K. 2008. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol. Cell. Biol. 28:3804–3816. doi:10.1128/MCB.00709-07.
   PubMed Web of Science ®Google Scholar
• Feng GS. 2006. Shp2 as a therapeutic target for leptin resistance and obesity. Expert Opin. Ther. Targets 10:135–142. doi:10.1517/14728222.10.1.135.
   PubMed Web of Science ®Google Scholar
• Banno R, Zimmer D, De Jonghe BC, Atienza M, Rak K, Yang W, Bence KK. 2010. PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J. Clin. Invest. 120:720–734. doi:10.1172/JCI39620.
   PubMed Web of Science ®Google Scholar
• Krajewska M, Banares S, Zhang EE, Huang X, Scadeng M, Jhala US, Feng GS, Krajewski S. 2008. Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. Am. J. Pathol. 172:1312–1324. doi:10.2353/ajpath.2008.070594.
   PubMedGoogle Scholar
• Zhang EE, Chapeau E, Hagihara K, Feng GS. 2004. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc. Natl. Acad. Sci. U. S. A. 101:16064–16069. doi:10.1073/pnas.0405041101.
   PubMedGoogle Scholar
• Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1:619–625.
   PubMed Web of Science ®Google Scholar
• Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. 1996. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159–161. doi:S014067369603173X.
   PubMed Web of Science ®Google Scholar
• Myers MG, Cowley MA, Munzberg H. 2008. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70:537–556. doi:10.1146/annurev.physiol.70.113006.100707.
   PubMed Web of Science ®Google Scholar